Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm sorry, I cannot figure out who is Dr. Baird of AVXT …
*** Looks like "that Baird" is a research/fund mgt. company. As opposed to "Dr." Baird of AVXT. ***
On AVAX website appears "Dr. David Berd" on Management Team:
http://avax-tech.com/about-avax/management/
Someone is making a big fuss, or I am not able to find Dr. BAIRD on avxt website …
.-
Link ... please!
Thanks
.-
I hope to see Bellerophone as KaloBios Pharmaceuticals (KBIO) in the night November 18 - 19, 2015 - from $2 to $10 and then to $40 in 3 days ...
.-
Audio from 5th Annual Marcum MicroCap Conference (June 1, 2016):
https://app.scoutfin.com/document.html?id=574f34c1cfa9f7cd550fca3b&_branch_match_id=266881379959762803
.-
Video about SERENZ and Pharmacies online:
Started selling SERENZ in British pharmacies.
Serenz Allergy Relief CO2 Spray 7.5g - Price: £15.00
The first allergy treatment to use carbon dioxide to relieve your nasal allergy symptoms!
http://www.expresschemist.co.uk/serenz-allergy-relief-co2-spray-7.5g.html#.VyCm5aRf3IU
Three injections containing the vaccine
Ovarian cancer survivors :
... As part of a clinical trial I participated in, tumors that were removed in my surgery were sent to a laboratory to be developed into a vaccine. It took some time for the vaccine to be prepared. Once it was ready, I received three injections containing the vaccine over a seven-week period...
http://www.cancercenter.com/community/survivors/karen-nugent/
Ovarian cancer survivors ( AVAX ) :
... As part of a clinical trial I participated in, tumors that were removed in my surgery were sent to a laboratory to be developed into a vaccine. It took some time for the vaccine to be prepared. Once it was ready, I received three injections containing the vaccine over a seven-week period...
http://www.cancercenter.com/community/survivors/karen-nugent/
You said: RS usually happens when a new CEO comes on board.
So, it means that there will probably be a RS ...
------------------------------------------
If I were the AVAX's CEO, for good of all, I would do so:
1) Update at same time, good news of O-VAX trial and financial plan completed.
2) Pay some Leading Analysts to introduce AVAX to retail investors and to Funds.
3) WAIT THE RISE OF SHARES, up about $ 0.5 TO ALLOW SOME INVESTORS TO RECOVER THEIR INVESTED CAPITAL.
4) ONLY NOW and not before point 1: Realize a Reverse Split 1 to 10 (maximum 1 to 50) to raise the share price to $ 5 - $ 25 and allow to Big Funds to invest on AVAX.
In addition, the current number of shares will be reduced from 10 to 50 times, this will make the stock AVAX always more interesting...
GOOD WORK TO CEO !!!
.-
We are all agreed: hopefully there will be good trial results and we can cure this disease!
I also hope there will be good updates WITHOUT Reverse Split ...
R / S would be a disaster for investors from long time like me!
I must wait for a take-off up to the level of $ 0.1 to recover my capital.
.-
I believe that it is spent too much time for a Refinancing Plan (from August to December)!
I mailed to Adele Sommerfeld, Chief Executive Officer, but she did not reply ...
AVAX will take-off after update about Refinancing Plan and final study results by the end of year or January 2016.
O-VAX Estimated Primary Completion Date: December 2015
Estimated Study Completion Date: January 2016
https://clinicaltrials.gov/ct2/show/NCT00660101?term=o-vax&rank=1
M-VAX Study Start Date: July 2016 ( new phase 3 )
Estimated Study Completion Date: January 2021
https://clinicaltrials.gov/ct2/show/NCT00477906?term=avax&rank=1
---------------------------------------------------------------
August 04, 2015 -
... SGC Canada Inc., is acting on behalf of AVAX with its creditors in negotiating its informal restructuring plan. David Holden, the Senior Corporate Advisor of SGC states that "AVAX will be effectively debt-free once the Financial Restructuring & Refinancing Plan is completed." The Board of AVAX has previously approved the engagement of Phoenix Corporate Finance Inc., a corporate finance firm which specializes in alternative financing, to advice, structure, and facilitates the distribution of a proposed Private Placement financing. Through select securities dealers in the US and Canada. AVAX intends to raise $45 million to fund its next round of clinical testing through the issuance of the Series A Convertible Preferred Shares.
http://www.avax-tech.com/news/2015/15_0804.php
.-
Audio Recordingand and Transcript from Leerink Rare Disease Roundtable:
https://leerink.metameetings.com/presentations/presenter/rd15/download_media.php?p=777&id=47dae40dfb
MP3 file format: prima.mp3
Transcript: prima.rtf
.-
Analyst Research Reports - Last Price: $20.00
https://commerce.us.reuters.com/purchase/advancedSearch.do?symbol=PBMD.O
http://www.reuters.com/finance/stocks/overview?symbol=PBMD.O
.-
How do you say that?
Perhaps the prediction $ 1.50 is closer to reality.
In recent months the peaks have been getting $ 1.40 to 1.50 ...
.-
The EMA, located in London, is the agency responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union. After dialogue between Prima and the EMA, the Agency has now confirmed in writing its endorsement of the development program of IMP321 in metastatic breast cancer.
Encouragingly, the planned Phase IIb study, to be called AIPAC (Active Immunotherapy PAClitaxel) is considered well designed by the Agency.
AIPAC is now expected to initiate in Europe during the 4th quarter of 2015. While the EMA never endorses any statement on the likelihood of future regulatory decisions, the Agency’s communication has suggested that the achievement of certain clinical endpoints may lead to Marketing Authorization in the EU based on this one pivotal study.
.-
Unfortunately, I have to admit my total loss of invested capital on ILNS ...
Shares purchased in over five years to ever lower prices ...
I sold all my shares ILNS and I bought twice shares AVXT ...
http://www.barchart.com/snapopinion/stocks/AVXT
http://ih.advfn.com/stock-market/USOTC/avax-technologies-inc-pn-ce-AVXT/stock-price
---------------------------------------------
My greetings to all on this board!
.-
Excuse me to you all ...
On this board, we read all the time of people who are excited as children, for increases of a cent ...
I believe that AVAX should be treated with more respect ... this is not market of candies or market of peanuts!
We don't need of desperate buyers for 51 K or 75 K shares ...
EXAMPLE: today, volume has been about 500 K share traded = about $ 12,000 ...
On Nasdaq Market, in others Stock, only a buyer pays that amount ...
We need of buyers at least of 1 million shares, each one of them = $ 25,000 ...
Then, we can see run price to $$$ and not penny !!!
If we want to attract serious investors with available capital, we need to talk about the potential and the objectives of AVAX, and avoid talking about paltry purchases of 50 K shares, and increases of few cent ...
.-
We don't need to wait that raining from sky the gold nuggets ...
If CEO believes in its biopharma, he should do:
1) At least a buyback of shares at these prices in clearance sale ...
2) Look for an agreement / merger with another small biopharma, to increase the supply in the pipeline and to give more confidence to the market ...
OTHERWISE, we will never see the payment of milestones by SHIRE or other Big Pharma.
They can buy 100 times ILNS, instead of paying milestone!
Mr. Maza wake up !!!
.-
To CEO Maza ...
I repeat my post of last May:
Mr. Maza, we need soon new Reverse Split ... at least 1 to 10 ...
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114020043
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114034003
.-
I agree!
Yesterday I asked to everybody:
Did someone call management about news?
Unfortunately no one replied ...
.-
It's only my feel!
If you read stories of Small Cap when were on OTC Market, you can imagine what AVAX + CTCA + FireBird are planning ...
.-
I hope so!
Did someone call management about news?
I think that they are planning new Company and maybe an IPO (Initial Public Offering ) between AVAX, CTCA and FireBird ...
.-
I doubt that they do plan on using the website, probably before August 4th, they had no confirmation about agreements with CTCA. Therefore, as guarantee they have renewed the website for only two years. If they had been certain to use their website, they would have renewed for at least 5 or 10 years. Or, they are pessimistic about the future of AVXT ...
Also a student of 14 years old can afford to renew its website for 10 years (cost ridiculous).
Otherwise, we can imagine that in the coffers of AVAX there is no money even to have lunch with a burger!
http://reports.internic.net/cgi/whois?whois_nic=avax-tech.com&type=domain
.-
Surely something very important is going to happen soon ...
Problem is whether or not there will be a Reverse Split unbeknownst to shareholders, and subsequent dilution ...
Results are completely opposite:
- Shareholders may multiply by 100, or by 1000 its capital ...
- Shareholders may recover some of their investment ...
In essence, "only" the new investors that will buy shares in the coming days will be holding a lottery ticket:
1) Make BINGO!
2) Retrieve the ticket price ...
Unfortunately, I am a pessimist, the management of AVAX has always treated its shareholders as stupid and naive ...
.-
I think that nobody will never see new website ...
After recent restructuring, AVAX and CTCA will become only one Company ...
Therefore, we will find all information about shares on website of CTCA ...
This is my prediction!
.-
Next week the share price will be same of last month ...
I am not BASHER, I own AVXT shares since 5 years ...
Unfortunately:
Without see a website, not knowing if there will be a reverse split, and what size ... 1-10 or 1-100 or 1-1000 …
Current Outstanding Shares: 142 million
Current price $ 0.0125
Probably they will reduce number of Outstanding Shares to 1.42 million, that means doing a Reverse Split 1-100 and set the value to $ 1.25 per Share.
Mathematically nothing changes, however, we will find in our portfolio a Stock on OTC market, at price of another Stock on Nasdaq market.
Especially, number of our Shares will be reduced by 100 times ...
AVXT if in future will reach $ 10 or $ 100 we must take into account the number of shares held.
In conclusion:
AVXT is great opportunity to buy now if "management" will not do the Reverse Split, or limit it to 1-10 ...
Buy now at $ 0.01- $ 0.05 and sell in few months for $ 1 - $ 5 (without Reverse Split) is a pipe dream ... but we all hope that it happens ...
Mr. Bing excuse me ...
Link: clinmedlibrary.com/articles/ijnn/ijnn-2-014.pdf
Received: January 06, 2015
Accepted: January 09, 2015
Published: January 12, 2015
http://clinmedlibrary.com/articles/ijnn/ijnn-2-014.pdf
.-
Exclusive: Alzheimer's group may scrap early look at coveted LILLY data.
Fri Jun 12, 2015
http://www.reuters.com/article/2015/06/12/us-alzheimers-elililly-data-idUSKBN0OS24Z20150612
.-
SHIRE's new page about VP20629 / SHP622 :
http://www.shiretrials.com/sitecore/content/studies/clinicaltrialsen/2014/11/19/10/58/shp-622-100?sc_lang=en
.-
Thanks Mr. Montanus !(correct post)
Clarification to new shareholders:
SHIRE
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
https://clinicaltrials.gov/ct2/show/NCT01898884?term=Friedreich%E2%80%99s+Ataxia+shire&rank=1
--------------------------------------------------------------
We can imagine what would be the pps if Shire will pay the first milestone of $ 10 million, as Mr. Bing wrote !
I hope that the usual "SHORTER" does not intervene to stop the price at the current level ...
.-
Thanks Mr. Montanus !
Clarification to new shareholders:
SHIRE
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
https://clinicaltrials.gov/ct2/show/NCT01898884?term=Friedreich%E2%80%99s+Ataxia+shire&rank=1
--------------------------------------------------------------
We can imagine what would be if the pps Shire will pay the first milestone of $ 10 million, as Mr. Bing wrote !
I hope that the usual "SHORTER" does not intervene to stop the price at the current level ...
.-
I agree, and I hope that last words of Mr. Bing are true ... and that his words are not his thoughts but what he already knows ...
.-
ILNS has a problem that started so many years ago ...
One or more persons who sell-off shares, even when there are good news!
Obviously, the goal is to confuse and destroy "the flock" of small shareholders ...
We understand that there is a big maneuverer, but nobody knows who he is ...
.-
Bankruptcy or change Ownership ???
.-
Does anyone know some update about bankruptcy or change of Ownership/Company ?
Website DELETED ...
.-
Does anyone know some update about bankruptcy or change of Ownership/Company ?
Website DELETED ...
.-
I'm a little envious of Mr. Bing because he knows when is right time to sell or to buy!
Shareholders must be very grateful to Mr. Bing, he is helping us with few words, knowing that he risks with SEC ...
Basically the message is this: buy stocks now that price is low!
Thanks very much ( Mr. Bing ... )
.-
[img][/img]